Assess the risk of fetal chromosomal abnormalities using fewer invasive procedures.
We offer screening systems for aneuploidies that combine markers and assays for high detection rates with low numbers of false positives. Such screening early in pregnancy allows expectant parents to make timely medical management decisions.
Our first and second trimester prenatal screening assays support both laboratories and clinics, with automated platforms available for AutoDELFIA® and DELFIA Xpress®. Victor2 D™ together with DELFIA® kits allow measurement of assays using semi-automated means.
Our safe, non-invasive first trimester screening tests are based on biochemical markers from maternal serum and provide expectant parents with a risk assessment for trisomy 21, 13, and 18.
PerkinElmer aneuploidy and pre-eclampsia screening products are not available in the USA. Products may not be available in all countries. For information on availability, please contact your local representative.
